Stay updated on AK104 Plus Anlotinib in NSCLC Clinical Trial

Sign up to get notified when there's something new on the AK104 Plus Anlotinib in NSCLC Clinical Trial page.
Latest website image capture
Clouds background image

Latest updates to the AK104 Plus Anlotinib in NSCLC Clinical Trial page

  1. Check
    7 days ago
    No Change Detected
  2. Check
    14 days ago
    No Change Detected
  3. Check
    21 days ago
    Change Detected
    Summary
    - Replaced version tag from v3.1.0 to v3.2.0 and added a prominent notice about government funding impact and operating status with references to NIH Clinical Center and official sources.
    Difference
    13%
    Check dated 2025-10-05T07:14:05.000Z thumbnail image
  4. Check
    28 days ago
    Change Detected
    Summary
    Updated the site/page version from v3.0.2 to v3.1.0, indicating a newer release. No other substantive content changes detected.
    Difference
    0.3%
    Check dated 2025-09-28T02:54:02.000Z thumbnail image
  5. Check
    43 days ago
    Change Detected
    Summary
    The page revision was bumped from v3.0.1 to v3.0.2, and the 'Back to Top' link was removed.
    Difference
    0.8%
    Check dated 2025-09-13T17:16:41.000Z thumbnail image
  6. Check
    50 days ago
    Change Detected
    Summary
    The web page has been updated from version 3.0.0 to version 3.0.1, indicating a revision in the content.
    Difference
    0.8%
    Check dated 2025-09-06T14:46:29.000Z thumbnail image
  7. Check
    57 days ago
    Change Detected
    Summary
    The web page has undergone significant updates, including the addition of a facility name and location details, while removing specific state, country, and city information.
    Difference
    10%
    Check dated 2025-08-30T11:33:43.000Z thumbnail image
  8. Check
    64 days ago
    Change Detected
    Summary
    The page has been updated to reflect a new completion status and a future date of August 19, 2025, while removing a previous status indicating that it was not actively recruiting and a date of March 3, 2025.
    Difference
    1%
    Check dated 2025-08-23T07:49:59.000Z thumbnail image

Stay in the know with updates to AK104 Plus Anlotinib in NSCLC Clinical Trial

Enter your email address, and we'll notify you when there's something new on the AK104 Plus Anlotinib in NSCLC Clinical Trial page.